Loading insider details...
Beta
Latest Form 4 (Jul 15, 2026): Other (see footnotes) of 9,304 XOMA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 15, 2026 | XOMA Royalty Corp (XOMA) | Other (see footnotes) | 9,304 | n/a |
| Jun 13, 2026 | Janux Therapeutics, Inc. (JANX) | Grant/Award | 5,500 | n/a |
| May 26, 2026 | XOMA Royalty Corp (XOMA) | Grant/Award | 3,586 | n/a |
| Jun 13, 2025 | Janux Therapeutics, Inc. (JANX) | Grant/Award | 3,750 | n/a |
| May 23, 2025 | XOMA Royalty Corp (XOMA) | Grant/Award | 5,971 | n/a |
| Jul 22, 2024 | Janux Therapeutics, Inc. (JANX) | Grant/Award | 5,000 | n/a |
| May 20, 2024 | ALPINE IMMUNE SCIENCES, INC. (ALPN) | Disposition to Issuer | 15,000 | n/a |
| May 17, 2024 | XOMA Corp (XOMA) | Grant/Award | 3,035 | n/a |
| Jan 4, 2024 | ALPINE IMMUNE SCIENCES, INC. (ALPN) | Grant/Award | 17,500 | n/a |
| May 19, 2023 | XOMA Corp (XOMA) | Grant/Award | 10,967 | n/a |